
The treatments are for eligible adults in England and Wales

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The company will gain a novel oral treatment for lung cancer

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

This is the first and only perioperative immunotherapy approved to treat early gastric cancers

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually

Almost three billion people globally are thought to be either overweight or obese

The pharma company will be the first global biopharma with end-to-end cell therapy capabilities in China

The pharma company has also pledged a $100bn investment in US infrastructure over the next decade

The company will provide Eliquis, its oral blood thinner, free of charge to Medicaid

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US

The company has invested $40bn in US R&D and manufacturing in the past seven years